Corindus to Report Fourth Quarter and Full Year 2018 Financial Results on March 12, 2019

Corindus Vascular Robotics, Inc. (NYSE American: CVRS), a leading developer of precision vascular robotics, today announced that it will release fourth quarter and full year 2018 financial and business results on Tuesday, March 12, 2019 after the close of the U.S. financial markets.

Mark Toland, President and Chief Executive Officer, and David Long, Chief Financial Officer, will host a conference call to discuss the results as follows:

    
      
        
          Date
        
        
           
        
        
           
        
        
          Tuesday, March 12, 2019
        
      
      
        
          Time
        
        
        
        
        
        
          4:30 p.m. EDT
        
      
      
        
          Toll free (U.S.)
        
        
        
        
        
        
          [phone]
        
      
      
        
          International
        
        
        
        
        
        
          [phone]
        
      
      
        
          Conference ID:
        
        
        
        
        
        
          5572188
        
      
      
        
          Webcast (live and replay)
        
        
        
        
        
        
          

www.corindus.com under the ‘Investor Relations’ section.

About Corindus Vascular Robotics, Inc.

Corindus Vascular Robotics, Inc. is a global technology leader in robotic-assisted vascular interventions. The Company’s CorPath® platform is the first FDA-cleared medical device to bring robotic precision to percutaneous coronary and vascular procedures. CorPath GRX is the second-generation robotic-assisted technology offering enhancements to the platform by adding important key upgrades that increase precision, improve workflow, and extend the capabilities and range of procedures that can be performed robotically. We are focused on developing innovative robotic solutions to revolutionize treatment of emergent conditions by providing specialized and timely medical care to patients around the world. For additional information, visit www.corindus.com, and follow @CorindusInc.

View source version on businesswire.com: https://www.businesswire.com/news/home/20190305005201/en/

Media Contact:Matter for CorindusJessica [e-mail]

Investor Contact:Lisa WilsonIn-Site Communications, Inc.T: [e-mail]